Free Republic

Newsweek: Congressional Investigators Say There is No Credible Record of A Prearranged Sell Order Between Martha Stewart and Her Broker Over Selling ImClone Stock -- Feds Are Now Going After Daughter of ImClone CEO; Bacanovic Expected to Plead the Fifth if Asked to Testify Before Congress NEW YORK, Jun 30, 2002 /PRNewswire via COMTEX/ -- As investigators begin focusing on whether Martha Stewart fabricated a cover-up over her sale of ImClone stock in December, congressional investigators tell Newsweek that Merrill Lynch documents they reviewed last week show no credible record of an arrangement between Stewart and her broker to sell...

WASHINGTON, Jun 30, 2002 (AP Online via COMTEX) -- Congressional investigators reviewing documents concerning Martha Stewart 's sale of ImClone stock have found no credible record of an arrangement with her broker to dump her shares when the stock fell below a certain price, according to a magazine report. House Energy and Commerce Committee investigators are examining whether Stewart had inside information when she sold nearly 4,000 shares of ImClone on Dec. 27 and have obtained her account through her lawyers. Investigators may want to talk to Stewart directly following an interview with her broker, Peter Bacanovic, a committee spokesman...

Ever since Enron melted down late last year the press and congressional committees have been on a steady witch-hunt to find similar corporate sneaks and the occasional Mr. Burns. And hey, to be fair the business world isn't the only institution having problems. Just ask the boys running the Catholic Church about management problems. By the time the stock markets closed this past Friday, it marked the fifth consecutive week of downturns. Sure the markets haven't hit that post-September 11 low yet, but they are trying as hard as they can. Terrorist warnings and Mid-East uncertainty surely aren't helping either,...

From the KausFiles ...Bonus question: Who was the star of the 1993 movie produced by Dr. Samuel Waksal, ImClone's recently-arrested, high-profile former chief? Hint: It's someone who doesn't wait for no stinkin' F.D.A.! ...Click here for the answer. -- The Last Party (Thanks to alert kf reader D. Moynihan.) 1:10 A.M.

* The legacy of the 90's is the legacy of the Little Lie. That is a lie which was told to help the teller, but was defended on the grounds that it HAD to be told to serve or protect a greater good. * Before Bob Shrum or Lanny Davis hit the speed dialer to call me, I am not blaming this on Bill Clinton. He didn't invent the Little Lie, although his "It depends on what your definition of 'is' is" will certainly be used, for the next two million years, to define it. * We did it...

Federal investigators are conducting a trade-by-trade analysis of all ImClone stock transactions made Dec. 26 and 27 — the critical days before the company admitted a major regulatory setback and its shares went into free fall. ImClone's ex-CEO Sam Waksal leaves his arraignment last week. Sources said both the U.S. attorney's office and the Securities and Exchange Commission are checking all trades from those days and whether insider tips from ImClone's ex-CEO Sam Waksal or Merrill Lynch broker Peter Bacanovic, a Waksal family friend, played a role in trading activity. ImClone trading was unusually active Dec. 27, the day before...

June 15, 2002 | 11:42 AM The Wacky Dr. Waksal by Frank DiGiacomo and Ian Blecher On Dec. 5, 2001, ImClone Systems, a biotech company that was seeking Food and Drug Administration approval for a promising anti-cancer drug called Erbitux, saw its stock peak at a price of $74 a share and begin an earthward trajectory. On the evening of Dec. 6, ImClone’s chief executive, Sam Waksal, 54, threw his annual Christmas party at the 5,000-square-foot Thompson Street loft that he calls home. Daily News owner Mort Zuckerman was in attendance, as well as former New York Times executive editor...